newsfilter
← Latest News
PR Newswire·

TransCode Therapeutics Announces 1-for-28 Reverse Stock Split

TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer...